Part of the Internal Medicine Commons

Works by S. S. Sørensen in Internal Medicine

2011

Regarding: Humar et al. The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients. Am J Transplant 2010;10:1228–1237, C. da Cunha-Bang, M. Iversen, S. A. Mortensen, A. Rasmussen, H. Sengeløv, S. S. Sørensen, J. Lundgren
Maura Iversen

Regarding: Humar et al. The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients, C. Da Cunha-Bang, M. Iversen, S. A. Mortensen, A. Rasmussen, H. Sengeløv, S. S. Sørensen, J. Lundgren
Maura Iversen